Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GSK American Depositary Shares Representing 2 Ordinary Shares GSK

Consumer Cyclical
GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with... see more

Recent & Breaking News (NYSE:GSK)

Transaction in Own Shares

UK Regulatory news services, from the LSE June 10, 2016

Phase III Study of Sirukumab Results

UK Regulatory news services, from the LSE June 8, 2016

Improved Recommended Offer for Energy Assets Group

UK Regulatory news services, from the LSE June 8, 2016

GlaxoSmithKline And Innoviva Plan To File A NDA For Triple Combination Therapy

Benzinga.com  June 2, 2016

Main Securities Market Notice

UK Regulatory news services, from the LSE June 2, 2016

Net Asset Value(s)

UK Regulatory news services, from the LSE June 2, 2016

Closed Triple Combined FF-UMEC-VI US Filing Plans

UK Regulatory news services, from the LSE June 2, 2016

Holding(s) in Company

UK Regulatory news services, from the LSE June 2, 2016

Regulatory Update on US Filing Plans for Closed Triple Combination Therapy FF/UMEC/VI in Patients With COPD

Marketwired June 2, 2016

Total Voting Rights

UK Regulatory news services, from the LSE June 1, 2016

Regulus Expands Clinical Trial Collaboration with GSK

PR Newswire June 1, 2016

Strimvelis receives EC marketing authorisation

UK Regulatory news services, from the LSE May 27, 2016

Board and Committee changes

UK Regulatory news services, from the LSE May 27, 2016

Daily Gearing Announcement

UK Regulatory news services, from the LSE May 24, 2016

Net Asset Value(s)

UK Regulatory news services, from the LSE May 24, 2016

Salford Lung Study Results Show COPD Patients Treated With Relvar(R) Ellipta(R) Achieve Superior Reduction in Exacerbations Compared to 'Usual Care'

Marketwired May 24, 2016

Second Price Monitoring Extn

UK Regulatory news services, from the LSE May 23, 2016

Arla Foods

UK Regulatory news services, from the LSE May 23, 2016

Banco Pan Announces Tender Offer

UK Regulatory news services, from the LSE May 23, 2016

Price Monitoring Extension

UK Regulatory news services, from the LSE May 23, 2016